A plan to conduct a study involving newborn babies in Guinea-Bissau has been aborted amidst a swirl of ethical debates and allegations of neo-colonialism. The trial aimed to assess the effects of administering the hepatitis B vaccine at birth, contrary to the current local practice of vaccinating at six weeks of age. However, global health officials quickly raised concerns surrounding the ethical implications of such research.
Suspended Study and Its Intent
The study, led by the Bandim Health Project, sought to involve 14,000 infants, with half receiving the hepatitis B vaccine immediately after birth. Researchers were interested in whether early vaccination could carry broad health benefits that extend beyond just preventing hepatitis B. This type of trial, however, drew criticism especially given that the World Health Organization (WHO) strongly recommends vaccinating at birth.
The controversy was heightened because the study was funded by the US under the Trump administration, with $1.6 million allocated to the University of Southern Denmark (SDU), responsible for managing the trial. The proposal involved withholding the potentially life-saving vaccine from half of the participating infants, a decision many considered unethical, particularly as the area has a notably high prevalence of the virus.
Reaction from WHO and Local Authorities
Walter Kazadi Mulombo, WHO’s representative in the region, emphasized the potential risks of withholding the vaccine, stressing its established efficacy and safety, widely administered in numerous countries for over thirty years. The WHO, alongside the Guinea-Bissau government, is pushing to incorporate the vaccination into the national immunization schedule sooner than the previously planned 2028 timeline.
The local government banned the trial and requested a review by the Africa Centres for Disease Control and Prevention. Health Minister Quinhin Nantote made it clear that no authorization was given for the trial to proceed, despite reports suggesting otherwise.
Accusations of Neo-colonialism
Among those critical of the trial was Dr. Gavin Yamey, who labeled the study as ‘neo-colonialism,’ pointing out that such research was not undertaken in countries like Denmark. This sparked questions about the ethical justification of conducting such sensitive trials in resource-limited settings while withholding WHO-endorsed vaccines.
Jakob Grauslund, Dean at SDU, confirmed that the trial had not officially begun. No babies had been enrolled, and the alleged revision of study protocols did not receive procedural clearance as claimed.
Moving Forward
Moving forward, authorities in Guinea-Bissau are keen to enhance their immunization schedule in line with global health recommendations. The setback highlights ongoing discussions around medical ethics, particularly the need for equitable health practices in low-income nations.
Photo by Hush Naidoo Jade Photography on Unsplash
